Stress test may help predict increased mortality risk in sleep apnea patients

May 20, 2013, American Thoracic Society

Many studies have shown that men and women who suffer from obstructive sleep apnea (OSA) - a disorder that causes breathing to halt intermittently during sleep – have a higher mortality rate than those who do not have the disorder. Now, a study from researchers at the Cleveland Clinic shows that OSA patients who also have poor functional capacity have an even greater risk of mortality and suggests that an assessment of functional capacity in this population can help physicians identify patients most at risk for death.

The results of the study will be presented at the ATS 2013 International Conference.

Previous studies have linked impaired functional capacity (IFC) with increased mortality, but this study evaluated IFC and its impact within the context of the OSA population. The researchers also wanted to determine if IFC remained a predictor of increased mortality even among OSA patients without coronary artery disease (CAD), another factor shown to be linked with increased mortality. For this study, CAD risk was measured using the Duke Score, or DTS, which evaluates an individual's capacity for exercise. Patients with abnormal DTS values were considered to have coronary artery disease.

"In our study, we sought to assess whether IFC is associated with increased mortality in patients with OSA and whether IFC is predictive of increased mortality after accounting for CAD," said study lead author Omar Minai, MD, staff physician in the Cleveland Clinic's Respiratory Institute and the Center. "We wanted to learn if the presence of IFC might be an effective tool in helping physicians identify which patients might have a higher risk for mortality."

For their study, the researchers reviewed the records of 1,533 OSA patients who had undergone both sleep testing, or , and tests utilizing within the prior three years. In addition to reviewing the data from the polysomnographs and echocardiograms, the researchers looked at demographic data, including smoking history, and comorbidities. Using this data, the investigators evaluated the association between IFC as determined by the stress echocardiogram and mortality within the total OSA patient population and found that overall, OSA patients with IFC were five times more likely to die than those without IFC.

Next, the researchers began identifying the variables that were associated with IFC in the total study population as well as in a subgroup of OSA patients without . After compiling their data, they found that female gender, history of smoking, increased body mass index, presence of comorbidities, abnormal exercise echocardiogram, abnormal heart rate recovery following the stress test and abnormal Duke Treadmill Score were all predictive of IFC. They also looked at ejection fractions, a measurement of how well the heart is pumping, and found that lower ejection fractions – which indicate poorer heart function – were also predictive of IFC.

When data were adjusted to account for the presence of variables including heart rate recovery, DTS and severity, the researchers found that OSA patients with IFC still were 2.7 times more likely to die than OSA patients without IFC. Among those with normal DTS, patients with IFC had a mortality risk that was 4.3 times that of those with normal . Finally, they looked at a subset of patients with both IFC and CAD and found that these patients had a higher mortality risk than patients who had only one of these factors.

"In our study population, IFC was a strong predictor of increased mortality, even among those with normal DTS," Dr. Minai said. "Clinically, this is important, because it suggests that, first, the addition of IFC may be able to improve the ability of a to predict mortality in OSA patients when DTS is normal and, second, it may also help identify a group of patients at especially high risk when IFC is found among patients with an abnormal DTS."

Explore further: Researchers identify a potential new risk for sleep apnea: Asthma

Related Stories

Researchers identify a potential new risk for sleep apnea: Asthma

May 19, 2013
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

OSA increases cardiovascular mortality in the elderly

September 7, 2012
Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce ...

Sleep apnea treatment may protect against heart failure

March 13, 2012
A nightly breathing treatment may do more than help people with obstructive sleep apnea get a good night's rest — it may also help prevent heart failure.

Bariatric patients with obstructive sleep apnea fail to show symptoms

August 9, 2012
A Rhode Island Hospital researcher has found that the majority of bariatric surgery patients being treated for obesity have clinically significant obstructive sleep apnea (OSA), but report fewer symptoms than other sleep ...

CPAP decreases cardiovascular mortality in elderly patients

May 15, 2011
Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain. ...

PAP therapy improves depressive symptoms in all patients with sleep apnea

June 12, 2012
Patients seen at the Cleveland Clinic Sleep Disorders Center who used positive airway pressure (PAP) to treat their obstructive sleep apnea (OSA) had improvements in their depressive symptoms, even if they followed the prescribed ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.